However, the study included a small number of participants and a shorter follow up time of only 48 weeks compared to other RCTs studying GLP-1 agonists
Studies indicate that people with FM are at increased risk for osteoporosis and while its early days, some studies suggest these drugs may be able to increase bone formation
BPC-157 (10 mg Vial) A synthetic peptide studied for tissue protection and accelerated healing.
However, the authors did speculate that since Trulicity is a larger molecule, it might have more struggles crossing the blood-brain barrier
Meanwhile, Ozempic and related medications like Wegovy continue providing proven benefits for millions of patients
It does not mimic, replace, or replicate the mechanism of GLP-1 medications